310
Participants
Start Date
December 15, 2020
Primary Completion Date
July 27, 2023
Study Completion Date
July 27, 2023
Recombinant nonimmunogenic staphylokinase
15 mg of drug reconstituted in 10 ml of 0.9% solution of NaCl given as single i.v. bolus over 10-15 seconds
Alteplase
Alteplase® is administered in accordance with the instructions for use for pulmonary embolism ( 10 mg bolus and 90 mg as IV infusion over 2 hours, maximum 100 mg). In patients weighing less than 65 kg, the total dose should not exceed 1.5 mg / kg.
D.D. Pletnev City Clinical Hospital, Moscow
I.V. Davydovskii City Clinical Hospital, Moscow
S.S. Yudin City Clinical Hospital, Moscow
V.V. Vinogradov City Clinical Hospital, Moscow
V.V. Veresaev City Clinical Hospital, Moscow
N.V. Sklifosovsky Research Institute for Emergency Medicine, Moscow
Sergiyev Posad Regional Clinical Hospital, Sergiyev Posad
Tver Regional Clinical Hospital, Tver'
Murmansk Regional Clinical Hospital, Murmansk
"Saint Petersburg Mariinskaya City Hospital", Saint Petersburg
Holy Martyr Elizabeth Saint Petersburg City Hospital, Saint Petersburg
Kursk Regional Clinical Hospital, Kursk
Belgorod Regional Clinical Hospital of St. Joseph, Belgorod
V.F. Dolgopolov Vyselki Central District Hospital, Vyselki
City Clinical Hospital of Emergency №25, Volgograd
Saratov Regional Clinical Cardiology Dispensary, Saratov
N.N. Burdenko Penza Regional Clinical hospital, Penza
G.A. Zakharyin Clinical hospital №6, Penza
V.P. Polyakov Samara Regional Clinical Cardiology Dispensary, Samara
City Clinical hospital №4, Vladimir
Kuzbass Cardiology center, Kemerovo
Krasnoyarsk Regional Clinical Hospital, Krasnoyarsk
S.P. Botkin City Clinical Hospital, Moscow
Supergene, LLC
INDUSTRY